← Back to Search

Labor Management Guidelines for Difficult Labor (REDUCED Trial)

N/A
Recruiting
Led By Stephen Wood, MD MSc
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Centers in Alberta that provide intrapartum care, have facilities to perform cesarean section and deliver at least 70 primparous women annually
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at delivery
Awards & highlights

REDUCED Trial Summary

This trial tests an intervention to reduce c-sections in first-time moms, without increasing harm to mother/baby, and is based on data from the Consortium for Safe Labor.

Who is the study for?
The REDUCED Trial is for first-time mothers at term (>= 37 weeks) with a baby in head-down position, delivering in Alberta centers that can perform cesarean sections and care during labor. Centers must handle over 70 such births yearly to participate.Check my eligibility
What is being tested?
This trial tests the effectiveness of sharing new guidelines on managing difficult labor among healthcare providers. The goal is to lower cesarean section rates without increasing risks to mother or baby by using data-driven management practices.See study design
What are the potential side effects?
Since this trial involves the implementation of knowledge rather than medication, there are no direct side effects from drugs. However, changes in labor management could potentially affect delivery experiences.

REDUCED Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

REDUCED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Cesarean section
Secondary outcome measures
Rate of blood transfusion
Rate of moderate or severe asphyxia or meets criteria for therapeutic cooling
Asphyxia Neonatorum
+6 more

REDUCED Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention centersExperimental Treatment1 Intervention
Application of a knowledge translation strategy, of new clinical practice guidelines on labor management, to physicians and nurses caring for women in labor. Intervention centers will receive knowledge translation of labor management guidelines
Group II: Control centersActive Control1 Intervention
No intervention at control centers

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
783 Previous Clinical Trials
745,929 Total Patients Enrolled
Stephen Wood, MD MScPrincipal InvestigatorUniversity of Calgary

Media Library

Knowledge Translation of labor management guidelines Clinical Trial Eligibility Overview. Trial Name: NCT02874443 — N/A
Cesarean Section Research Study Groups: Intervention centers, Control centers
Cesarean Section Clinical Trial 2023: Knowledge Translation of labor management guidelines Highlights & Side Effects. Trial Name: NCT02874443 — N/A
Knowledge Translation of labor management guidelines 2023 Treatment Timeline for Medical Study. Trial Name: NCT02874443 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for enrollment in this experiment currently available?

"Indeed, the details posted on clinicaltrials.gov confirm that this study is actively recruiting participants. This medical trial was initially published on October 1st 2016 and has been updated recently in February of 2023. It seeks to include 100000 patients from a single site."

Answered by AI

How many individuals can join this trial before it reaches capacity?

"Affirmative. The information on clinicaltrials.gov verifies that this research is presently enrolling participants. It was initially published on October 1st 2016 and most recently updated February 24th 2023, with the goal of recruiting 100000 patients from a single location."

Answered by AI
~27049 spots leftby Dec 2026